The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
Abstract
CONTEXT: Chronic kidney disease (CKD) is common. Kidney disease severity can be classified by estimated glomerular filtration rate (GFR) and albuminuria, but more accurate information regarding risk for progression to kidney failure is required for clinical decisions about testing, treatment, and referral. OBJECTIVE: To develop and validate predictive models for progression of CKD. DESIGN, SETTING, AND PARTICIPANTS: Development and validation of prediction models using demographic, clinical, and laboratory data from 2 independent Canadian cohorts of patients with CKD stages 3 to 5 (estimated GFR, 10-59 mL/min/1.73 m(2)) who were referred to nephrologists between April 1, 2001, and December 31, 2008. Models were developed using Cox proportional hazards regression methods and evaluated using C statistics and integrated discrimination improvement for discrimination, calibration plots and Akaike Information Criterion for goodness of fit, and net reclassification improvement (NRI) at 1, 3, and 5 years. MAIN OUTCOME MEASURE: Kidney failure, defined as need for dialysis or preemptive kidney transplantation. RESULTS: The development and validation cohorts included 3449 patients (386 with kidney failure [11%]) and 4942 patients (1177 with kidney failure [24%]), respectively. The most accurate model included age, sex, estimated GFR, albuminuria, serum calcium, serum phosphate, serum bicarbonate, and serum albumin (C statistic, 0.917; 95% confidence interval [CI], 0.901-0.933 in the development cohort and 0.841; 95% CI, 0.825-0.857 in the validation cohort). In the validation cohort, this model was more accurate than a simpler model that included age, sex, estimated GFR, and albuminuria (integrated discrimination improvement, 3.2%; 95% CI, 2.4%-4.2%; calibration [Nam and D'Agostino χ(2) statistic, 19 vs 32]; and reclassification for CKD stage 3 [NRI, 8.0%; 95% CI, 2.1%-13.9%] and for CKD stage 4 [NRI, 4.1%; 95% CI, -0.5% to 8.8%]). CONCLUSION: A model using routinely obtained laboratory tests can accurately predict progression to kidney failure in patients with CKD stages 3 to 5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J., & Kattan, M. W. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c30fb2 · Cited by 5,170
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D'Agostino, R. B., & Steyerberg, E. W. (2011) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,453
Tutorial in biostatistics: competing risks and multi‐state models
Putter, H., Fiocco, M., & Geskus, R. B. (2007) · Statistics in Medicine · doi:10.1002/sim.2712 · Cited by 2,440
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
Keith, D. S., Nichols, G. A., Gullion, C. M., Brown, J. B., & Smith, D. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.6.659 · Cited by 1,684
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
Kim, W. R., Biggins, S. W., Kremers, W. K., Wiesner, R. H., Kamath, P. S., Benson, J. T., Edwards, E., & Therneau, T. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801209 · Cited by 1,486
Pencina, M. J., & D'Agostino, R. B. (2004) · Statistics in Medicine · doi:10.1002/sim.1802 · Cited by 1,444
Greenland, P. (2008) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300
Weiner, D. E., Tighiouart, H., Amin, M. G., Stark, P. C., MacLeod, B., Griffith, J. L., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000123691.46138.e2 · Cited by 1,176
Prevalence of chronic kidney disease in population-based studies: Systematic review
Zhang, Q.-L., & Rothenbacher, D. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-117 · Cited by 1,021
Bicarbonate Supplementation Slows Progression of CKD and Improves Nutritional Status
de Brito-Ashurst, I., Varagunam, M., Raftery, M. J., & Yaqoob, M. M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111205 · Cited by 857
Lasser, K. E., Himmelstein, D. U., & Woolhandler, S. (2006) · American Journal of Public Health · doi:10.2105/ajph.2004.059402 · Cited by 609
Pozen, M. W., D'Agostino, R. B., Selker, H. P., Sytkowski, P. A., & Hood, W. B. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405173102001 · Cited by 599
Cardiovascular disease and chronic renal disease: A new paradigm
Sarnak, M. J., & Levey, A. S. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70239-3 · Cited by 586
Sarnak, M. J., Greene, T., Wang, X., Beck, G., Kusek, J. W., Collins, A. J., & Levey, A. S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00009 · Cited by 521
Kent, D. M., & Hayward, R. A. (2007) · JAMA · doi:10.1001/jama.298.10.1209 · Cited by 505
Selker, H. P., Beshansky, J. R., Griffith, J. L., Aufderheide, T. P., Ballin, D. S., Bernard, S. A., Crespo, S. G., Feldman, J. A., Fish, S. S., Gibler, W. B., et al. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_1-199812010-00002 · Cited by 350
Evaluation of the Performance of Survival Analysis Models: Discrimination and Calibration Measures
D'Agostino, R. B., & Nam, B.-H. (2003) · Handbook of Statistics · doi:10.1016/s0169-7161(03)23001-7 · Cited by 338
C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Wilson, P. W. F., Pencina, M., Jacques, P., Selhub, J., D'Agostino, R., & O'Donnell, C. J. (2008) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.831198 · Cited by 299
Predicting initiation and progression of chronic kidney disease: Developing renal risk scores
Taal, M. W., & Brenner, B. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001794 · Cited by 282
Levin, A., Djurdjev, O., Beaulieu, M., & Er, L. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.06.023 · Cited by 270
Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney Disease
Schwarz, S., Trivedi, B. K., Kalantar-Zadeh, K., & Kovesdy, C. P. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02101205 · Cited by 263
Keane, W. F., Zhang, Z., Lyle, P. A., Cooper, M. E., de Zeeuw, D., Grunfeld, J.-P., Lash, J. P., McGill, J. B., Mitch, W. E., Remuzzi, G., et al. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01381005 · Cited by 202
Prevalence of chronic kidney disease
Bellizzi, V. (2008) · Giornale Italiano di Nefrologia · Cited by 176
Hemmelgarn, B. R. (2010) · JAMA · doi:10.1001/jama.2010.303 · Cited by 164
Population based screening for chronic kidney disease: cost effectiveness study
Manns, B., Hemmelgarn, B., Tonelli, M., Au, F., Chiasson, T. C., Dong, J., Klarenbach, S., & on behalf of the Alberta Kidney Disease Network (2010) · BMJ · doi:10.1136/bmj.c5869 · Cited by 161
O’Hare, A. M., Bertenthal, D., Walter, L. C., Garg, A. X., Covinsky, K. E., Kaufman, J. S., Rodriguez, R. A., & Allon, M. (2007) · Kidney International · doi:10.1038/sj.ki.5002078 · Cited by 134
Predicting the Risk of Dialysis and Transplant Among Patients With CKD: A Retrospective Cohort Study
Johnson, E. S., Thorp, M. L., Platt, R. W., & Smith, D. H. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.04.026 · Cited by 111
Renal risk scores: Progress and prospects
Taal, M. W., & Brenner, B. M. (2008) · Kidney International · doi:10.1038/ki.2008.36 · Cited by 106
Barriers to implementing cardiovascular risk tables in routine general practice
Steenkiste, B. V., Weijden, T. V. D., Stoffers, H. E. J. H., & Grol, R. (2004) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430310004489 · Cited by 104
Jain, A. K., McLeod, I., Huo, C. Y., Cuerden, M. S., Akbari, A., Tonelli, M. A., van Walraven, C., Quinn, R. R., Hemmelgarn, B. R., Oliver, M. J., et al. (2009) · Kidney International · doi:10.1038/ki.2009.158 · Cited by 97
Barriers to Routine Risk-Score Use for Healthy Primary Care Patients: Survey and Qualitative Study
Müller‐Riemenschneider, F., Holmberg, C., Rieckmann, N., Kliems, H., Rufer, V., Müller-Nordhorn, J., & Willich, S. N. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.66 · Cited by 87
Batsis, J. A., & López-Jiménez, F. A. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-29 · Cited by 77
Geddes, C. C., Fox, J. G., Allison, M. E. M., Boulton-Jones, J. M., & Simpson, K. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.1.67 · Cited by 61
A Before-and-After Study of Fracture Risk Reporting and Osteoporosis Treatment Initiation
Leslie, W. D., Morin, S. N., & Lix, L. M. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-9-201011020-00007 · Cited by 31
Validation of the Toronto Formula to Predict Progression in IgA Nephropathy
Mackinnon, B., Fraser, E. P., Cattran, D., Fox, J. G., & Geddes, C. (2008) · Nephron Clinical Practice · doi:10.1159/000145458 · Cited by 31
Subgroup Analyses in Clinical Trials
Kent, D. M., & Hayward, R. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmc073436 · Cited by 11
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Self-citationMoons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0698 · Cited by 5,147
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
Lok, C. E., Huber, T. S., Lee, T., Shenoy, S., Yevzlin, A. S., Abreo, K., Allon, M., Asif, A., Astor, B. C., Glickman, M. H., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.12.001 · Cited by 2,590
Levey, A. S., & Coresh, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60178-5 · Cited by 1,841
Chronic Kidney Disease Diagnosis and Management: A Review
Chen, T. K., Knicely, D. H., & Grams, M. E. (2019) · JAMA · doi:10.1001/jama.2019.14745 · Cited by 1,811
Metadata
- Authors
- Tangri, N.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-04-20
- Volume
- 305
- Issue
- 15
- Pages
- 1553
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2165817472
- Cited by
- 1,348
- References
- 44
- FWCI
- 39.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.